Table 3.
n = 82 | B | Std. Error | 95%CI | p |
---|---|---|---|---|
Clinical parameter | ||||
Age | − 0.070 | − 0.043 | − 0.16 to 0.01 | 0.11 |
PSA | 0.0004 | 0.004 | − 0.08 to 0.07 | 0.99 |
PSAD | 3.99 | 1.85 | 0.70 to 8.12 | 0.03 |
Clinical and biopsy parameter | ||||
Age | − 0.09 | 0.05 | − 0.19 to 0.001 | 0.06 |
PSA | − 0.01 | 0.05 | − 0.12 to 0.07 | 0.81 |
PSAD | 4.03 | 2.13 | 0.34 to 8.84 | 0.05 |
ISUP GG | 0.74 | 0.40 | − 0.02 to 1.55 | 0.04 |
Infiltration | 0.03 | 0.01 | 0.01 to 0.05 | 0.02 |
Clinical, biopsy, and MRI parameter | ||||
PSA | − 0.07 | 0.05 | − 0.19 to 0.03 | 0.217 |
PSAD | 5.69 | 2.65 | 1.03 to 11.47 | 0.032 |
ISUP GG | 0.47 | 0.41 | − 0.32 to 1.30 | 0.25 |
Infiltration | 0.02 | 0.01 | − 0.01 to 0.04 | 0.11 |
Localization | 0.93 | 0.84 | − 0.72 to 2.65 | 0.27 |
MRI T stage | 1.43 | 0.74 | 0.02 to 0.09 | 0.05 |
LCC | 0.02 | 0.03 | − 0.02 to 0.09 | 0.37 |
MRI magnetic resonance imaging, PSA prostate-specific antigen, PSAD prostate-specific antigen density, ISUP International Society of Urological Pathology, GG grade group, LCC length to prostatic pseudocapsule, IL index lesion, T stage Tumor stage, BCR biochemical recurrence, RPE radical prostatectomy, B unstandardized coefficient, Std. Error standard error, CI confidence interval, p p-value
p-values <0.05 are given as statistically significant